)
Changchun High-Tech Industry (Group) (000661) investor relations material
Changchun High-Tech Industry (Group) Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
9M 2026 revenue was ¥8.25B, down 15.86% YoY; net income attributable to shareholders was ¥586.1M, down 49.68%.
Adjusted for non-recurring items, attributable net income was ¥687.2M, down 45.84%; operating cash flow rose 235% to ¥2.42B.
Financial highlights
Q3 revenue was ¥2.71B, down 15.46% YoY; attributable net income was ¥110.8M, down 39.12%.
9M operating costs totaled ¥7.23B versus ¥8.20B YoY; selling expenses declined to ¥3.01B from ¥3.76B, while R&D expenses fell to ¥1.44B from ¥1.73B.
9M net income was ¥516.5M versus ¥1.06B YoY; attributable net income was ¥586.1M, with minority shareholders recording a ¥69.6M loss.
Segment performance
Jin Sai Pharmaceutical 9M revenue was ¥6.68B, down 18.71% YoY; profit attributable to parent owners was ¥778M, down 45.26%.
Baike Biotech revenue was ¥564M, up 18.84% YoY, with a ¥96M attributable loss; Huakang Pharmaceutical revenue declined 9.13% to ¥492M and attributable profit fell 10.47% to ¥32M.
High-Tech Real Estate revenue rose 180.02% to ¥1.52B, with a ¥3M attributable loss; ¥1.042B from internal hotel-related asset restructuring was eliminated in consolidated results.
- Revenue and profit declined sharply year-over-year, but cash flow and innovation pipeline advanced.000661
Q2 2026 - Revenue and profit declined sharply, but R&D and global licensing advanced key pipelines.000661
Q4 2025 - Revenue and profit declined sharply year-over-year, but cash flow and real estate improved.000661
Q1 2026 - Net profit dropped 58.23% year-over-year amid revenue decline and higher asset impairments.000661
Q3 2025 - Net profit dropped 42.85% year-over-year as R&D spending and new launches increased.000661
Q2 2025 - Revenue and net profit fell significantly in Q3 2024, with only Huakang Pharma showing growth.000661
Q3 2024 - Revenue up 7.63% but net profit down 20.40% as real estate surges and biopharma softens.000661
Q2 2024 - Net profit fell 43% on lower sales and higher R&D, with strong cash returns to shareholders.000661
Q4 2024 - Net profit plunged 44.95% in Q1 2025 as rising costs offset modest revenue growth.000661
Q1 2025
Next Changchun High-Tech Industry (Group) earnings date
Next Changchun High-Tech Industry (Group) earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)